SUMMARY Analysis of mitochondrial DNA from patients with Leber's hereditary optic neuropathy and their relatives showed that the previously reported mutation at base pair (bp) 11778, shown by loss of a recognition site for the restriction endonuclease SfaNI, was present in only four out of eight families. This mutation was associated with a poor prognosis for visual recovery, whereas four of five affected males without the 11778 bp mutation followed for four years or more had regained useful vision. All but one of the subjects showing the SfaNI site loss had a variable mixture of mutant and normal mitochondrial DNA in peripheral blood, and the relative proportions appeared to be correlated with the risk of developing or transmitting Leber's hereditary optic neuropathy.
Leber's hereditary optic neuropathy (LHON) gives rise to acute or subacute blindness, usually in young adult males. Loss of visual acuity is generally severe (6/60 or less) and persistent, although limited improvement is sometimes observed.' 2LHON is transmitted exclusively through the maternal line; in contrast to X linked inheritance, the descendants of affected males are never affected. Between 70 and 100% of the daughters of female carriers transmit the disease to their sons, and 50 to 100% of the sons of carriers develop LHON. About 85% of patients with LHON are male, and 18% of female carriers are affected.2 3 These observations are compatible with the hypothesis that the disease may be caused by mutation of mitochondrial DNA (mt DNA). 3 4 Human mt DNA is a closed circular molecule 16 569 base pairs (bp) in length, which is only transmitted by females; it has been entirely sequenced and is known to code for 13 polypeptides of the mitochondrial respiratory chain and oxidative phosphorylation systemr. group.bmj.com on June 20, 2017 -Published by http://jmg.bmj.com/ Downloaded from four years. The fifth patient (case 7) had persistent severe visual loss after four years; his affected brother had recovered 30 months after onset. The two patients who had been followed for less than four years (cases 19 and 22) both had affected brothers who had regained useful vision. In contrast, the four patients with the 11778 bp mutation who had developed blindness four years or more before study had not shown any signs of recovery. None of the affected relatives of these patients had regained useful vision.
Discussion
This study indicates that LHON is genetically heterogeneous, associated with a mitochondrial DNA mutation at position 11778 detected by SfaNI in only four of eight families. It is unlikely that this mutation is a chance association with LHON, as it has not been observed in 72 control subjects from a variety of racial backgrounds (13 and this study). Conversely, the mutation has been found in LHON pedigrees from the USA (both black and caucasoid), Canada, and Finland in the previous report ' 
